Natco Pharma inches up on expecting India, Brazil, Canada markets to be revenue drivers in FY20

10 Jun 2019 Evaluate

Natco Pharma is currently trading at Rs. 543.00, up by 0.15 points or 0.03% from its previous closing of Rs. 542.85 on the BSE.

The scrip opened at Rs. 547.00 and has touched a high and low of Rs. 547.00 and Rs. 543.00 respectively. So far 1392 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 849.00 on 12-Sep-2018 and a 52 week low of Rs. 482.00 on 28-May-2019.

Last one week high and low of the scrip stood at Rs. 558.90 and Rs. 522.00 respectively. The current market cap of the company is Rs. 9916.94 crore.

The promoters holding in the company stood at 48.71%, while Institutions and Non-Institutions held 28.52% and 22.77% respectively.

Natco Pharma is expecting India, Brazil and Canada markets to be its revenue drivers during the current financial year, recording growth of 30% to 40%. The company expects India business alone is likely to grow by about 15% to 20%.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

888.60 -14.95 (-1.65%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×